Noxopharm Ltd. has released a press release.
New data confirms cancer-fighting potential
Earlier from Noxopharm
- Noxopharms Sofra assets to be presented at global conference
- Noxopharm progresses US regulatory strategy
- New data shows SOF-SKN active ingredient efficacy
- Innovative collaboration further expands Sofra platform